Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1157]
News [2523]
Articles [155]
Editorials [8]
Conferences [103]
elearning [18]
Geriatric cognitive evaluation and prostate cancer
Prof Nicolas Mottet - University Hospital of Saint-Etienne, St. Etienne, France
Geriatric cognitive evaluation and prostate cancer ( Prof Nicolas Mottet - University Hospital of Saint-Etienne, St. Etienne, France )
15 Nov 2017
More focus on prostate cancer in geriatrics is needed
Dr Iwona Skoneczna - Szpital św. Elżbiety, Warsaw, Poland
More focus on prostate cancer in geriatrics is needed ( Dr Iwona Skoneczna - Szpital św. Elżbiety, Warsaw, Poland )
15 Nov 2017
Advances in hormone sensitive prostate cancer and castration resistance...
Prof Heather Payne, Dr Gero Kramer, Prof Maria De Santis and Prof Kurt Miller
Advances in hormone sensitive prostate cancer and castration resistance management ( Prof Heather Payne, Dr Gero Kramer, Prof Maria De Santis and Prof Kurt Miller )
24 Oct 2017
Editor's Choice for September 2017
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for September 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
27 Sep 2017
Bladder cancer's relationship with the urinary and gut microbiomes
Dr Jeremy Burton - Lawson Health Research Institute, London, Canada
Bladder cancer's relationship with the urinary and gut microbiomes ( Dr Jeremy Burton - Lawson Health Research Institute, London, Canada )
21 Sep 2017
ESMO 2017 roundup with Dr Bishal Gyawali (1/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
Nivolumab and ipilimumab for metastatic kidney cancer
Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France
Nivolumab and ipilimumab for metastatic kidney cancer ( Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France )
11 Sep 2017
ESMO 2017: Prostate cancer highlights
Prof Karim Fizazi, Prof Stephane Oudard, Dr Bertrand Tombal & Prof Maria De...
ESMO 2017: Prostate cancer highlights ( Prof Karim Fizazi, Prof Stephane Oudard, Dr Bertrand Tombal & Prof Maria De Santis )
10 Sep 2017
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma
Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )
10 Sep 2017
ESMO 2017: New prostate data from STAMPEDE
Prof Martin Bögemann and Prof Nicholas James
ESMO 2017: New prostate data from STAMPEDE ( Prof Martin Bögemann and Prof Nicholas James )
10 Sep 2017
RANGE trial of ramucirumab for urothelial cancer
Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA
RANGE trial of ramucirumab for urothelial cancer ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )
10 Sep 2017
Phase Ib/II trial of combination PD-1 therapy against kidney cancer
Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA
Phase Ib/II trial of combination PD-1 therapy against kidney cancer ( Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA )
9 Sep 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation